Peter David Suzdak - Net Worth and Insider Trading

Peter David Suzdak Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter David Suzdak owns 3 companies in total, including Rexahn Pharmaceuticals Inc (REXN) , Aeolus Pharmaceuticals Inc (AOLS) , and Opus Genetics Inc (IRD) .

Click here to see the complete history of Peter David Suzdak’s form 4 insider trades.

Insider Ownership Summary of Peter David Suzdak

Ticker	Comapny	Transaction Date	Type of Owner
REXN	Rexahn Pharmaceuticals Inc	2018-02-28	director & Chief Executive Officer
AOLS	Aeolus Pharmaceuticals Inc	2013-05-08	director
IRD	Opus Genetics Inc	2013-02-04	Chief Executive Officer

Peter David Suzdak Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Peter David Suzdak Ownership Network

Ownership Network List of Peter David Suzdak

No Data

Ownership Network Relation of Peter David Suzdak

Peter David Suzdak Owned Company Details

What does Rexahn Pharmaceuticals Inc do?

Who are the key executives at Rexahn Pharmaceuticals Inc?

Peter David Suzdak is the director & Chief Executive Officer of Rexahn Pharmaceuticals Inc. Other key executives at Rexahn Pharmaceuticals Inc include Chief Medical Officer Ely Benaim , Chief Business Officer Lisa Nolan , and director & President and CEO Douglas J Swirsky .

Rexahn Pharmaceuticals Inc (REXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Rexahn Pharmaceuticals Inc (REXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rexahn Pharmaceuticals Inc (REXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Rexahn Pharmaceuticals Inc (REXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rexahn Pharmaceuticals Inc Insider Transactions

No Available Data

What does Aeolus Pharmaceuticals Inc do?

Who are the key executives at Aeolus Pharmaceuticals Inc?

Peter David Suzdak is the director of Aeolus Pharmaceuticals Inc. Other key executives at Aeolus Pharmaceuticals Inc include President and CEO John L Mcmanus , Chief Financial Officer Russell Skibsted , and 10 percent owner Mark Lappe .

Aeolus Pharmaceuticals Inc (AOLS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aeolus Pharmaceuticals Inc (AOLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aeolus Pharmaceuticals Inc (AOLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aeolus Pharmaceuticals Inc (AOLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aeolus Pharmaceuticals Inc Insider Transactions

No Available Data

What does Opus Genetics Inc do?

Who are the key executives at Opus Genetics Inc?

Peter David Suzdak is the Chief Executive Officer of Opus Genetics Inc. Other key executives at Opus Genetics Inc include Chief Executive Officer George Magrath , SVP & Operations & Bus. Dev. Ronil A. Patel , and director & President and CEO Mina Sooch .

Opus Genetics Inc (IRD) Insider Trades Summary

Over the past 18 months, Peter David Suzdak made no insider transaction in Opus Genetics Inc (IRD). Other recent insider transactions involving Opus Genetics Inc (IRD) include a net purchase of 130,000 shares made by George Magrath , a net purchase of 2,000 shares made by , and a net purchase of 10,000 shares made by Benjamin R Yerxa .

In summary, during the past 3 months, insiders sold 0 shares of Opus Genetics Inc (IRD) in total and bought 110,000 shares, with a net purchase of 110,000 shares. During the past 18 months, 0 shares of Opus Genetics Inc (IRD) were sold and 155,500 shares were bought by its insiders, resulting in a net purchase of 155,500 shares.

Opus Genetics Inc (IRD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Opus Genetics Inc Insider Transactions

No Available Data

Peter David Suzdak Mailing Address

Above is the net worth, insider trading, and ownership report for Peter David Suzdak. You might contact Peter David Suzdak via mailing address: 1204 Meadowlark Drive, Towson Md 21286.

Discussions on Peter David Suzdak

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.